课题基金 / 基金详情

Glutamatergic compounds for treating drug addiction: Preclinical models

Glutamatergic compounds for treating drug addiction: Preclinical models
用于治疗药物成瘾的谷氨酸化合物：临床前模型
批准号：
9353054
负责人：
Eliot Gardner
金额：
$50.89万
依托单位：
NATIONAL INSTITUTE ON DRUG ABUSE
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/9353054
关键词：
Addictive BehaviorAnimal ModelBehaviorBiochemicalBiological AssayBrainBudgetsChemicalsCollaborationsCuesDrug AddictionDrug IndustryElectrical Stimulation of the BrainExposure toGlutamatesGoalsHigh Pressure Liquid ChromatographyImmunoblottingIntravenousLaboratory AnimalsLiteratureMediatingMetabotropic Glutamate ReceptorsMicrodialysisNeurotransmittersPeer ReviewPharmaceutical PreparationsPolymerase Chain ReactionPre-Clinical ModelProteinsPsychological reinforcementPublicationsRNARelapseReportingResearchResearch Project GrantsReverse TranscriptionRewardsRoleSamplingSelf AdministrationStressSystemTechniquesWestern BlottingWorkaddictioncravingfollow-upin vivointerestpre-clinicalpreference

项目摘要

项目成果

Eliot Gardner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Due to extremely severe cuts in budget and staffing, no progress was made on this research project during the reporting period. This is unfortunate, as this project had been - in previous years - one of our most productive research endeavors, resulting in a large number of publications in the peer-reviewed scientific literature. We are presently pursuing external research collaborations, especially with entities within the pharmaceutical industry, that may allow us to once again pursue this work and follow up on the promising findings that we had obtained in previous years on this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Basic brain mechanisms underlying drug addiction, craving, and relapse
Basic brain mechanisms underlying drug addiction, craving, and relapse
Endocannabinoid brain mechanisms and addiction
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
海外基金